On May 5, 2025, NKGen Biotech, Inc. signed an agreement to sell 20,849,725 shares of common stock to CEO Paul Y. Song at $0.1271 per share for a total of $2,650,000, along with a warrant to purchase an additional 41,699,449 shares. This transaction is a related party deal and was approved by the Board.